SCHEMBL24328492

SCHEMBL24328492

O=C(c1ccc2c(c1)-c1ccccc1Cc1ccccc1-c1ccccc1C2)c1ccc2c(c1)-c1ccccc1C21c2ccccc2-c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 2/20 0.53
▸ HTR2C P28335 2/20 0.46
▸ HTR2B P41595 2/20 0.46
▸ DRD2 P14416 1/20 0.46
▸ ADRA1D P25100 1/20 0.46
▸ HTR2A P28223 1/20 0.46
▸ HTR7 P34969 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ ADRA1B P35368 1/20 0.46
▸ PDK2 Q15119 5/20 0.43
▸ KDM4E B2RXH2 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP1A2 P05177 3/20 0.41
▸ ADRA2A P08913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19225657 0.88 SRD5A2 (0.60) SRD5A2HTR2CHTR2BDRD2ADRA1D
SCHEMBL22036983 0.88 SRD5A2 (0.60) SRD5A2HTR2CHTR2BDRD2ADRA1D
SCHEMBL6128510 0.87 PDK2 (0.53) PDK2KDM4EMAPTALDH1A1LMNA
SCHEMBL12200611 0.83 PDK2 (0.54) PDK2TDP1
SCHEMBL10968736 0.81 SRD5A2 (0.77) SRD5A2HTR2CHTR2BDRD2ADRA1D
SCHEMBL1970132 0.78 SRD5A2 (0.72) SRD5A2HTR2CHTR2BDRD2ADRA1D
SCHEMBL134285 0.77 PDK2 (0.58) PDK2TDP1L3MBTL1
SCHEMBL134286 0.77 PDK2 (0.58) PDK2TDP1L3MBTL1
SCHEMBL29114 0.77 PDK2 (0.58) PDK2TDP1L3MBTL1
SCHEMBL17767361 0.76 SRD5A2 (0.75) SRD5A2HTR2CHTR2BDRD2ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
US-20220123249-A1 ORGANIC LIGHT EMITTING ELEMENT KYULUX, INC. (JP) 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 SRD5A2 1208/4885HTR2C 204/4885HTR2B 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback